Intercostobrachial Nerve preserving in breast cancer treatment for pain management
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2020/03/024285
- Lead Sponsor
- McMasterUniversity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Females aged 18 years and older.
2.Diagnosed invasive breast cancer.
3.Planned ALND (not sentinel lymph node biopsy) either alone or with planned mastectomy or breast conserving surgery.
4.The ICBN is preservable (as confirmed in the OR).
5.Cognitive ability and language skills required to complete the outcome measures.
6.Provision of informed consent
The patient has chronic pain or a chronic pain syndrome for which they have received regular medication (i.e. opioid, anti-convulsant, anti-spasmodic, anti-depressant, anti-inflammatory) or routine pain intervention (e.g. nerve blocks) during the past 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method